Kannaway Makes Its Debut On European CBG Market

Kannaway made its debut on the European cannabigerol (CBG) market on Thursday by its parent company Medical Marijuana Inc. MJNA.

The move comes on the heels of Kannnaway's entering into the U.S. cannabinol market with the introduction of two new CBN isolate products.

Each bottle of Kannaway's newly released product contains 200 milligrams of CBD and 500 milligrams of CBG coming from European organic hemp.

Products are certified via the company's Triple Lab Testing process, the San Diego company confirmed.

"As CBD continues to grow in acceptance around the world, the market for cannabinoids like CBG also expands," noted Kannaway CEO Blake Schroeder. "Our company intends to continue to be at the forefront of expanding access to cannabinoids just as we have been with CBD."

Meantime, earlier this year, Kannaway tapped NHL and network marketing veteran Mike Hartman to its Sports Team to endorse CBD, and also Carolyn Dielmann Connolly as its new brand ambassador.

In January, Kannaway was named the Most Popular Cannabidiol (CBD) MLM Company in HealthMJ's new 2020 list.

Courtesy image

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisNewsMarketsPress Releasescannabigerolcannabinolcannabis industryCBGEuropeInc.Kannawaymedical marijuanaOrganic Hemp Seed Oil
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry? Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.


Loading...